US Stock MarketDetailed Quotes

CLPT ClearPoint Neuro

Watchlist

12.220
-0.850-6.50%

Close Mar 10 16:00 ET

12.030
-0.190-1.55%

Post 20:01 ET

337.67MMarket Cap-17.46P/E (TTM)

ClearPoint Neuro Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ClearPoint Neuro Q4 2024 Earnings Date

Currency：USDFeb 26, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	8.23M	7.77M	-458.67K
Miss Est.	+20.85%	+14.11%	-5.57%
EPS	-0.16	-0.20	-0.04
Miss Est.	+14.06%	-5.26%	-22.55%

Analyst Rating

Strong Buy

Mar 3, 2025

ClearPoint Neuro Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 9.101M	--
--	2025/Q1	-- / 8.240M	--
Feb 26, 2025	2024/Q4	7.771M / 8.230M	--
Nov 7, 2024	2024/Q3	8.122M / 7.780M	--
Aug 7, 2024	2024/Q2	7.858M / 7.330M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 9.101M--

--2025/Q1-- / 8.240M--

Feb 26, 20252024/Q47.771M / 8.230M--

Nov 7, 20242024/Q38.122M / 7.780M--

Aug 7, 20242024/Q27.858M / 7.330M--

Unlock Free Earnings Estimates

Open Account

ClearPoint Neuro Earnings Reports

ClearPoint Neuro | 10-K: FY2024 Annual Report

Feb 26 17:22 ET

ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results Achieved Record Revenue for 2024 and Growth of 31%; Reduced 2024 Operational Cash Burn by 35%

Feb 26 16:07 ET

ClearPoint Neuro | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:21 ET

ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Third Quarter 2024 Results

Nov 7, 2024 16:14 ET

Trending Stocks

Symbol Mini Chart % Chg

Lantheus

LNTH

+3.45%

Collegium Pharmaceutical

COLL